Lupus Nephritis
Showing 26 - 50 of 174
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Human umbilical cord mesenchymal stem cells
- Interleukin-2
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022
Lupus Nephritis Trial in Worldwide (Mycophenolate Mofetil/Mycophenolic Acid, Obinutuzumab, Placebo)
Active, not recruiting
- Lupus Nephritis
- Mycophenolate Mofetil/Mycophenolic Acid
- +4 more
-
La Jolla, California
- +45 more
Nov 14, 2022
Telitacicept and Belimumab in Active Lupus Nephritis in Real
Not yet recruiting
- Lupus Nephritis
- +2 more
- (no location specified)
Oct 18, 2022
Lupus Nephritis Trial in Worldwide (ianalumab s.c. q4w, ianalumab s.c. q12w, s.c.)
Recruiting
- Lupus Nephritis
- ianalumab s.c. q4w
- +2 more
-
Fairfax, Virginia
- +37 more
Oct 14, 2022
Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)
Not yet recruiting
- Lupus Nephritis
- Type 1 Diabetes Mellitus
- autologous adoptive T regulatory cell transfer.
-
Cairo, EgyptAin shams university, faculty of medicine
Sep 30, 2022
Lupus Nephritis Trial (Daxdilimab, Placebo (Normal Saline))
Not yet recruiting
- Lupus Nephritis
- Daxdilimab
- Placebo (Normal Saline)
- (no location specified)
Sep 12, 2022
Lupus Nephritis Trial (Mycophenolate Mofetil)
Not yet recruiting
- Lupus Nephritis
- Mycophenolate Mofetil
- (no location specified)
Sep 9, 2022
Lupus Nephritis Trial in Worldwide (CFZ533, Placebo)
Active, not recruiting
- Lupus Nephritis
- CFZ533
- Placebo
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- +20 more
Aug 23, 2022
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
Lupus Nephritis Trial in Worldwide (Placebo, Nipocalimab, Standard-of-care treatment)
Not yet recruiting
- Lupus Nephritis
- Placebo
- +2 more
-
Glendale, Arizona
- +59 more
Aug 2, 2022
Lupus Nephritis Trial in Hong Kong (Pre-emptive increase of immunosuppressive treatments, Prednisolone and/or AZA/MMF)
Recruiting
- Lupus Nephritis
- Pre-emptive increase of immunosuppressive treatments
- Prednisolone and/or AZA/MMF
-
Hong Kong, Hong Kong
- +1 more
Jul 25, 2022
Patients With Systemic Lupus Erythematosus
Recruiting
- Lupus Nephritis
-
Bruxelles, BelgiumCliniques universitaires Saint-Luc
Jun 29, 2022
Lupus Nephritis Trial in Assiut (Anti JAK1,2)
Active, not recruiting
- Lupus Nephritis
- Anti JAK1,2
-
Assiut, Assuit, EgyptManal Hassanien
Jun 21, 2022
Lupus Nephritis Trial in Stockholm (Repeat kidney biopsy)
Recruiting
- Lupus Nephritis
- Repeat kidney biopsy
-
Stockholm, SwedenKarolinska University Hospital
Jun 16, 2022
Lupus Nephritis Trial in Hong Kong (Tacrolimus, Mycophenolate mofetil)
Recruiting
- Lupus Nephritis
- Tacrolimus
- Mycophenolate mofetil
-
Hong Kong, Hong KongThe University of Hong Kong
May 16, 2022
Precision Medicine in LN: A Multicenter Proof-of-concept Study
Recruiting
- Lupus Nephritis
- Systemic Lupus Erythematosus
-
Vigo, Pontevedra, SpainIRIDIS-VIGO Group (Investigation in Rheumatology and Immune-Medi
Apr 28, 2022